Azilsartan: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
===[[Azilsartan kamedoxomil|Azilsartan Kamedoxomil (Edarbi)]]=== | ===[[Azilsartan kamedoxomil|Azilsartan Kamedoxomil (Edarbi)]]=== | ||
===[[Azilsartan | ===[[Azilsartan kamedoxomil and chlorthalidone|Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)]]=== | ||
==Overview== | ==Overview== | ||
Latest revision as of 05:32, 22 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Azilsartan Kamedoxomil (Edarbi)
Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)
Overview
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of hypertension to lower blood pressure. Common adverse reactions include hypotension/orthostatic hypotension.
Category
Angiotensin 2 Receptor Blocker